D N Haylock
Overview
Explore the profile of D N Haylock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nilsson S, Prince H, Wall D, Haylock D
Cytotherapy
. 2007 Apr;
9(3):231-5.
PMID: 17464754
This review provides insight into two clinical trials conducted with ex vivo manipulated CD34+ cells. The first was an attempt to deliver a gene therapy for treatment of HIV and...
2.
Levesque J, Takamatsu Y, Nilsson S, Haylock D, Simmons P
Blood
. 2001 Aug;
98(5):1289-97.
PMID: 11520773
Mobilized progenitor cells currently represent the most commonly used source of hematopoietic progenitor cells (HPCs) to effect hematopoietic reconstitution following myeloablative chemotherapies. Despite their widespread use, the molecular mechanisms responsible...
3.
Simmons P, Levesque J, Haylock D
Ann N Y Acad Sci
. 2001 Jul;
938:196-206; discussion 206-7.
PMID: 11458509
Current data suggest that interplay between two classes of molecules contributes to the regulation of hematopoiesis: hematopoietic growth factors, which regulate the survival, proliferation, and development of primitive hematopoietic cells...
4.
Levesque J, Zannettino A, Pudney M, Niutta S, Haylock D, Snapp K, et al.
Immunity
. 1999 Oct;
11(3):369-78.
PMID: 10514015
Cellular interactions are critical for the regulation of hematopoiesis. The sialomucin PSGL-1/CD162 mediates the attachment of mature leukocytes to P-selectin. We now show that PSGL-1 also functions as the sole...
5.
Moore S, Haylock D, Levesque J, McDiarmid L, Samels L, To L, et al.
Blood
. 1998 Sep;
92(7):2461-70.
PMID: 9746786
The interaction between p145(c-KIT) and p210(bcr-abl) in transduced cell lines, and the selective outgrowth of normal progenitors during long-term culture of chronic myeloid leukemia (CML) cells on stroma deficient in...
6.
Makino S, Haylock D, Dowse T, Trimboli S, Niutta S, To L, et al.
J Hematother
. 1997 Nov;
6(5):475-89.
PMID: 9368184
A major potential application for ex vivo culture of hematopoietic progenitor cells is the treatment of cytopenia following high-dose chemotherapy and hematopoietic transplantation. We have previously postulated that infusion of...
7.
Haylock D, Horsfall M, Dowse T, Ramshaw H, Niutta S, Protopsaltis S, et al.
Blood
. 1997 Oct;
90(6):2260-72.
PMID: 9310477
The ligand for flt-3 (FLT3L) exhibits striking structural homology with stem cell factor (SCF) and monocyte colony-stimulating factor (M-CSF) and also acts in synergy with a range of other hematopoietic...
8.
White D, Hutchins C, Turczynowicz S, Suttle J, Haylock D, Hughes T, et al.
Pathology
. 1997 Aug;
29(3):289-93.
PMID: 9271020
Patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) often exhibit clonal chromosomal abnormalities. Using a probe for the centromeric region of chromosome 8, fluorescence in situ hybridization (FISH)...
9.
To L, Haylock D, Simmons P, Juttner C
Blood
. 1997 Apr;
89(7):2233-58.
PMID: 9116266
No abstract available.
10.
Lewis I, Haylock D, Moore S, To L, Hughes T
Leukemia
. 1997 Apr;
11(4):581-7.
PMID: 9096699
Manipulation of autologous bone marrow cells (BM) for transplantation in chronic myeloid leukemia (CML) to enrich for normal cells is a novel approach that may improve survival for patients not...